Ampio reports positive results for ampion treatment in covid-19 patients

Ampio reports positive results for ampion treatment in covid-19 patients.ampio pharmaceuticals inc - ampion found to be safe and well-tolerated with no drug related adverse events.ampio pharmaceuticals inc - study met its primary endpoint for safety and tolerability of iv ampion treatment.ampio pharma - ampion-treated patients showed greater improvement versus patients treated with standard of care including anti-viral therapies.ampio pharmaceuticals - believe ampion may be effective in interrupting inflammatory cascade associated with covid-19.ampio pharmaceuticals inc - patients will be followed over upcoming months to complete safety endpoint assessments for phase 1 clinical trial.
AMPE Ratings Summary
AMPE Quant Ranking